![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 15323 |
FusionGeneSummary for GPX3_S100A8 |
![]() |
Fusion gene information | Fusion gene name: GPX3_S100A8 | Fusion gene ID: 15323 | Hgene | Tgene | Gene symbol | GPX3 | S100A8 | Gene ID | 2878 | 6279 |
Gene name | glutathione peroxidase 3 | S100 calcium binding protein A8 | |
Synonyms | GPx-P|GSHPx-3|GSHPx-P | 60B8AG|CAGA|CFAG|CGLA|CP-10|L1Ag|MA387|MIF|MRP8|NIF|P8 | |
Cytomap | 5q33.1 | 1q21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | glutathione peroxidase 3GPx-3extracellular glutathione peroxidaseglutathione peroxidase 3 (plasma)plasma glutathione peroxidase | protein S100-A8calgranulin Acalprotectin L1L subunitcystic fibrosis antigenleukocyte L1 complex light chainmigration inhibitory factor-related protein 8urinary stone protein band A | |
Modification date | 20180519 | 20180522 | |
UniProtAcc | P22352 | P05109 | |
Ensembl transtripts involved in fusion gene | ENST00000388825, ENST00000521722, ENST00000517973, | ENST00000368732, ENST00000368733, ENST00000477801, | |
Fusion gene scores | * DoF score | 8 X 11 X 3=264 | 4 X 5 X 2=40 |
# samples | 14 | 6 | |
** MAII score | log2(14/264*10)=-0.915111102413487 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/40*10)=0.584962500721156 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: GPX3 [Title/Abstract] AND S100A8 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GPX3 | GO:0051289 | protein homotetramerization | 3693360 |
Tgene | S100A8 | GO:0002523 | leukocyte migration involved in inflammatory response | 12626582 |
Tgene | S100A8 | GO:0006914 | autophagy | 19935772 |
Tgene | S100A8 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 19935772 |
Tgene | S100A8 | GO:0030593 | neutrophil chemotaxis | 12626582 |
Tgene | S100A8 | GO:0050729 | positive regulation of inflammatory response | 12626582 |
Tgene | S100A8 | GO:0070488 | neutrophil aggregation | 12626582 |
Tgene | S100A8 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 19935772 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AW794509 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000388825 | ENST00000368732 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
3UTR-3CDS | ENST00000388825 | ENST00000368733 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
3UTR-intron | ENST00000388825 | ENST00000477801 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
intron-3CDS | ENST00000521722 | ENST00000368732 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
intron-3CDS | ENST00000521722 | ENST00000368733 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
intron-intron | ENST00000521722 | ENST00000477801 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
intron-3CDS | ENST00000517973 | ENST00000368732 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
intron-3CDS | ENST00000517973 | ENST00000368733 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
intron-intron | ENST00000517973 | ENST00000477801 | GPX3 | chr5 | 150407982 | + | S100A8 | chr1 | 153362669 | + |
Top |
FusionProtFeatures for GPX3_S100A8 |
![]() |
Hgene | Tgene |
GPX3 | S100A8 |
Protects cells and enzymes from oxidative damage, bycatalyzing the reduction of hydrogen peroxide, lipid peroxides andorganic hydroperoxide, by glutathione. | S100A8 is a calcium- and zinc-binding protein whichplays a prominent role in the regulation of inflammatory processesand immune response. It can induce neutrophil chemotaxis andadhesion. Predominantly found as calprotectin (S100A8/A9) whichhas a wide plethora of intra- and extracellular functions. Theintracellular functions include: facilitating leukocytearachidonic acid trafficking and metabolism, modulation of thetubulin-dependent cytoskeleton during migration of phagocytes andactivation of the neutrophilic NADPH-oxidase. Activates NADPH-oxidase by facilitating the enzyme complex assembly at the cellmembrane, transferring arachidonic acid, an essential cofactor, tothe enzyme complex and S100A8 contributes to the enzyme assemblyby directly binding to NCF2/P67PHOX. The extracellular functionsinvolve proinflammatory, antimicrobial, oxidant-scavenging andapoptosis-inducing activities. Its proinflammatory activityincludes recruitment of leukocytes, promotion of cytokine andchemokine production, and regulation of leukocyte adhesion andmigration. Acts as an alarmin or a danger associated molecularpattern (DAMP) molecule and stimulates innate immune cells viabinding to pattern recognition receptors such as Toll-likereceptor 4 (TLR4) and receptor for advanced glycation endproducts(AGER). Binding to TLR4 and AGER activates the MAP-kinase and NF-kappa-B signaling pathways resulting in the amplification of theproinflammatory cascade. Has antimicrobial activity towardsbacteria and fungi and exerts its antimicrobial activity probablyvia chelation of Zn(2+) which is essential for microbial growth.Can induce cell death via autophagy and apoptosis and this occursthrough the cross-talk of mitochondria and lysosomes via reactiveoxygen species (ROS) and the process involves BNIP3. Can regulateneutrophil number and apoptosis by an anti-apoptotic effect;regulates cell survival via ITGAM/ITGB and TLR4 and a signalingmechanism involving MEK-ERK. Its role as an oxidant scavenger hasa protective role in preventing exaggerated tissue damage byscavenging oxidants. Can act as a potent amplifier of inflammationin autoimmunity as well as in cancer development and tumor spread.The iNOS-S100A8/A9 transnitrosylase complex directs selectiveinflammatory stimulus-dependent S-nitrosylation of GAPDH andprobably multiple targets such as ANXA5, EZR, MSN and VIM byrecognizing a [IL]-x-C-x-x-[DE] motif; S100A8 seems to contributeto S-nitrosylation site selectivity. {ECO:0000269|PubMed:12626582,ECO:0000269|PubMed:15331440, ECO:0000269|PubMed:15598812,ECO:0000269|PubMed:15642721, ECO:0000269|PubMed:16258195,ECO:0000269|PubMed:19087201, ECO:0000269|PubMed:19122197,ECO:0000269|PubMed:19935772, ECO:0000269|PubMed:21487906,ECO:0000269|PubMed:22363402, ECO:0000269|PubMed:22808130,ECO:0000269|PubMed:25417112}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GPX3_S100A8 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GPX3_S100A8 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GPX3_S100A8 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | GPX3 | P22352 | DB00143 | Glutathione | Glutathione peroxidase 3 | small molecule | approved|investigational|nutraceutical |
Tgene | S100A8 | P05109 | DB01593 | Zinc | Protein S100-A8 | small molecule | approved|investigational |
Tgene | S100A8 | P05109 | DB01373 | Calcium | Protein S100-A8 | small molecule | approved|nutraceutical |
Top |
RelatedDiseases for GPX3_S100A8 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GPX3 | C0014175 | Endometriosis | 2 | CTD_human |
Hgene | GPX3 | C0024121 | Lung Neoplasms | 2 | CTD_human |
Hgene | GPX3 | C0028754 | Obesity | 2 | CTD_human |
Hgene | GPX3 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | GPX3 | C0015624 | Fanconi Syndrome | 1 | CTD_human |
Hgene | GPX3 | C0021655 | Insulin Resistance | 1 | CTD_human |
Hgene | GPX3 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | GPX3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | GPX3 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
Tgene | S100A8 | C0011615 | Dermatitis, Atopic | 1 | CTD_human |
Tgene | S100A8 | C0011616 | Contact Dermatitis | 1 | CTD_human |
Tgene | S100A8 | C0022548 | Keloid | 1 | CTD_human |
Tgene | S100A8 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Tgene | S100A8 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |